Trial Profile
Maraviroc to Augment Rehabilitation Outcomes After Stroke
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms MAROS
- 12 Jul 2021 Status changed from recruiting to discontinued.
- 18 Sep 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2021.
- 18 Sep 2019 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2021.